|
🐜
|
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.
19 auth.
P. James,
Nathan T Connell,
B. Ameer,
J. Di Paola,
J. Eikenboom,
Nicolas Giraud,
S. Haberichter,
Vicki Jacobs-Pratt,
B. Konkle,
C. McLintock,
...
Simon McRae,
Robert R Montgomery,
J. O’Donnell,
Nikole Scappe,
R. Sidonio,
V. Flood,
Nedaa M Husainat,
Mohamad A. Kalot,
R. Mustafa
|
8 |
2021 |
8
🐜
|
|
🦁
|
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.
9 auth.
S. Haberichter,
M. Balistreri,
P. Christopherson,
P. Morateck,
S. Gavazova,
D. Bellissimo,
...
M. Manco‐Johnson,
J. Gill,
R. Montgomery
|
7 |
2006 |
7
🦁
|
|
🦁
|
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).
21 auth.
S. Haberichter,
G. Castaman,
U. Budde,
I. Peake,
A. Goodeve,
F. Rodeghiero,
A. Federici,
J. Batlle,
D. Meyer,
C. Mazurier,
...
J. Goudemand,
J. Eikenboom,
R. Schneppenheim,
J. Ingerslev,
Z. Vorlová,
D. Habart,
L. Holmberg,
S. Lethagen,
J. Pasi,
F. Hill,
R. Montgomery
|
7 |
2008 |
7
🦁
|
|
🐜
|
Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.
19 auth.
V. Flood,
V. Flood,
J. Gill,
P. Morateck,
P. Christopherson,
K. Friedman,
S. Haberichter,
S. Haberichter,
B. Branchford,
R. Hoffmann,
...
T. Abshire,
J. D. Paola,
W. Hoots,
C. Leissinger,
J. Lusher,
M. Ragni,
A. Shapiro,
R. Montgomery,
R. Montgomery
|
7 |
2010 |
7
🐜
|
|
🐜
|
Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.
19 auth.
V. Flood,
V. Flood,
J. Gill,
P. Morateck,
P. Christopherson,
K. Friedman,
S. Haberichter,
S. Haberichter,
B. Branchford,
R. Hoffmann,
...
T. Abshire,
J. D. Paola,
W. Hoots,
C. Leissinger,
J. Lusher,
M. Ragni,
A. Shapiro,
R. Montgomery,
R. Montgomery
|
7 |
2010 |
7
🐜
|
|
🐜
|
Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment.
14 auth.
Helen V. Yarovoi,
Dubravka Kufrin,
Don E. Eslin,
M. A. Thornton,
S. Haberichter,
Q. Shi,
Hua Zhu,
R. Camire,
Steve S. Fakharzadeh,
M. Kowalska,
...
David A. Wilcox,
B. Sachais,
Robert R. Montgomery,
M. Poncz
|
7 |
2003 |
7
🐜
|
|
🐬
|
The physiological function of von Willebrand's factor depends on its tubular storage in endothelial Weibel-Palade bodies.
Grégoire Michaux,
K. Abbitt,
L. Collinson,
S. Haberichter,
K. Norman,
D. Cutler
|
7 |
2006 |
7
🐬
|
|
🐜
|
Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis
8 auth.
S. Kanaji,
S. Fahs,
Q. Shi,
Q. Shi,
S. Haberichter,
S. Haberichter,
...
Robert R. Montgomery,
Robert R. Montgomery
|
6 |
2012 |
6
🐜
|
|
🐜
|
Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis
8 auth.
S. Kanaji,
S. Fahs,
Q. Shi,
Q. Shi,
S. Haberichter,
S. Haberichter,
...
Robert R. Montgomery,
Robert R. Montgomery
|
6 |
2012 |
6
🐜
|
|
🐜
|
Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2.
23 auth.
Sven Jäckel,
K. Kiouptsi,
M. Lillich,
T. Hendrikx,
Avinash B. Khandagale,
Bettina Kollar,
N. Hörmann,
Cora Reiss,
S. Subramaniam,
E. Wilms,
...
Katharina Ebner,
M. Brühl,
P. Rausch,
J. Baines,
S. Haberichter,
B. Lämmle,
C. Binder,
K. Jurk,
Z. Ruggeri,
S. Massberg,
U. Walter,
W. Ruf,
C. Reinhardt
|
6 |
2017 |
6
🐜
|
